equityflowunderstand the flow and follow it
EquityFlowCompanies › Zumutor Biologics

Zumutor Biologics

Biotech · Bengaluru, IN

Develops NK-cell antibody immunotherapies for cancer

In the network

Shares the most investors with (number = shared investors):

Funding history

DateRoundAmount
Dec 2021Series A
Biotech Zumutor Biologics raised $6.2M in a Series A4 led by Siana Capital, with Accel and Bharat Innovation Fund, to advance its prostate-cancer antibody.
$6.2M

Investors

Tap an investor to see what else they have backed.

Other companies in Biotech

Other companies in IN

Other companies at Series A stage

Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.